ebiratide: analog of ACTH 4-9; RN given in USAN; RR given in Toxlit 10/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6918103 |
| SCHEMBL ID | 140882 |
| MeSH ID | M0160041 |
| Synonym |
|---|
| hoe-427 |
| ebiratide |
| 105250-86-0 |
| (4s)-5-[[(2s)-1-[[(2s)-1-[[(2r)-6-amino-1-[[(2s)-1-(8-aminooctylamino)-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2s)-2-amino-4-methylsulfonylbutanoyl]amino]-5 |
| l-methionyl-l-glutamyl-l-histidyl-l-phenylalanyl-d-lysyl-n-(8-aminooctyl)-l-phenylalaninamide s,s-dioxide |
| ebiratidum |
| ebiratidum [latin] |
| ebiratida [spanish] |
| cm5j1v7aut , |
| ebiratide [inn] |
| unii-cm5j1v7aut |
| ebiratida |
| SCHEMBL140882 |
| DTXSID60883159 |
| Q27275529 |
| (4s)-5-[[(2s)-1-[[(2s)-1-[[(2r)-6-amino-1-[8-aminooctyl-[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2s)-2-amino-4-methylsulfonylbutanoyl]amino]-5- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 14 (93.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 4 (19.05%) | 5.53% |
| Reviews | 1 (4.76%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (76.19%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||